Annual Total Liabilities
$32.06 M
+$1.55 M+5.09%
31 December 2023
Summary:
4D Molecular Therapeutics annual total liabilities is currently $32.06 million, with the most recent change of +$1.55 million (+5.09%) on 31 December 2023. During the last 3 years, it has risen by +$118.00 thousand (+0.37%). FDMT annual total liabilities is now -75.56% below its all-time high of $131.20 million, reached on 31 December 2019.FDMT Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$51.08 M
+$19.30 M+60.75%
30 September 2024
Summary:
4D Molecular Therapeutics quarterly total liabilities is currently $51.08 million, with the most recent change of +$19.30 million (+60.75%) on 30 September 2024. Over the past year, it has increased by +$19.40 million (+61.24%). FDMT quarterly total liabilities is now -61.07% below its all-time high of $131.20 million, reached on 31 December 2019.FDMT Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FDMT Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.1% | +61.2% |
| 3 y3 years | +0.4% | +209.9% |
| 5 y5 years | -74.3% | - |
FDMT Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -6.7% | +5.1% | at high | +209.9% |
| 5 y | 5 years | -75.6% | +5.1% | -61.1% | +257.5% |
| alltime | all time | -75.6% | +5.1% | -61.1% | +257.5% |
4D Molecular Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $51.08 M(+60.7%) |
| June 2024 | - | $31.78 M(+8.4%) |
| Mar 2024 | - | $29.32 M(-8.5%) |
| Dec 2023 | $32.06 M(+5.1%) | $32.06 M(+1.2%) |
| Sept 2023 | - | $31.68 M(+15.8%) |
| June 2023 | - | $27.36 M(+7.6%) |
| Mar 2023 | - | $25.41 M(-16.7%) |
| Dec 2022 | $30.51 M | $30.51 M(+6.2%) |
| Sept 2022 | - | $28.72 M(-5.6%) |
| June 2022 | - | $30.42 M(+5.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $28.87 M(-16.0%) |
| Dec 2021 | $34.38 M(+7.6%) | $34.38 M(+108.6%) |
| Sept 2021 | - | $16.48 M(+15.4%) |
| June 2021 | - | $14.29 M(-48.4%) |
| Mar 2021 | - | $27.68 M(-13.3%) |
| Dec 2020 | $31.94 M(-75.7%) | $31.94 M(+13.9%) |
| Sept 2020 | - | $28.04 M(-78.6%) |
| Dec 2019 | $131.20 M(+5.3%) | $131.20 M(+6.8%) |
| June 2019 | - | $122.80 M(-1.4%) |
| Dec 2018 | $124.56 M(+165.5%) | $124.56 M |
| Dec 2017 | $46.91 M | - |
FAQ
- What is 4D Molecular Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics annual total liabilities year-on-year change?
- What is 4D Molecular Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics quarterly total liabilities year-on-year change?
What is 4D Molecular Therapeutics annual total liabilities?
The current annual total liabilities of FDMT is $32.06 M
What is the all time high annual total liabilities for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high annual total liabilities is $131.20 M
What is 4D Molecular Therapeutics annual total liabilities year-on-year change?
Over the past year, FDMT annual total liabilities has changed by +$1.55 M (+5.09%)
What is 4D Molecular Therapeutics quarterly total liabilities?
The current quarterly total liabilities of FDMT is $51.08 M
What is the all time high quarterly total liabilities for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high quarterly total liabilities is $131.20 M
What is 4D Molecular Therapeutics quarterly total liabilities year-on-year change?
Over the past year, FDMT quarterly total liabilities has changed by +$19.40 M (+61.24%)